Primary pulmonary involvement of Fusarium solani in a lung transplant recipient.
A case of cavitary lung disease caused by Fusarium solani in a lung transplant recipient is presented. A mechanism for development of this infection is proposed. Lipid complex amphotericin B (Abelcet) was effective in eradicating this infection. To our knowledge, invasive lung disease caused by the Fusarium species has not been previously reported in a solid organ transplant recipient.
Arney
K L
KL
Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston 29425, USA.
Tiernan
R
R
Judson
M A
MA
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D004338:Drug Combinations; D005670:Fusarium; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008172:Lung Diseases, Fungal / Q000175:diagnosis* / Q000188:drug therapy; D016040:Lung Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000175:diagnosis* / Q000188:drug therapy; D010713:Phosphatidylcholines / Q000627:therapeutic use; D010715:Phosphatidylglycerols / Q000627:therapeutic use; D012988:Soil Microbiology
D000935:Antifungal Agents; D004338:Drug Combinations; D007166:Immunosuppressive Agents; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D000666:Amphotericin B